Colon Cancer Market 2022
Starting with the overview of Colon Cancer Market, it presents an overall analysis of the latest trends that are prevalent in the industry. The report begins with the description of the market surroundings and the analysis of the size and forecast of product or service based on regions and applications. In addition to it, the report also introduces the market competitive landscape among the vendors and manufacturers that contribute to the growth of the product or service. The company profiling and market price analysis in relation to the value chain features is also covered in the report. The data experts have examined and scrutinized the industry trends in the key regions. 2022 has been considered as the base year, with the forecast period extending to 2027.
Change in bowel habits or blood in stool are the major symptoms of colon cancer. Attributable epidemiological factors can be precancerous growth in the colon or genetic mutation. The American Society of Clinical Oncology (ASCO) recommends patients affected with colon cancer, for testing of genetic mutation in the KRAS gene which accounts for about 30% to 40% of colon tumors.
There are three primary recommended therapies for treating colon cancer – surgery, chemotherapy and radiation. Surgical procedures such as colonoscopy, endoscopic mucosal resection, colectomy and laparoscopy are preferred in early-stage and invasive colon cancer treatment therapy. Besides, chemotherapy involves administration of drugs that destroy cancer cells, usually recommended after the surgery to reduce the risk of recurrence.
Request for Table of Content@https://www.persistencemarketresearch.com/toc/5423
In addition, targeted drugs such as bevacizumab (Avastin), cetuximab (Erbitux), panitumumab (Vectibix) and regorafenib (Stivarga) are administered to patients with advanced colon cancer. Radiation therapy utilizes powerful X-ray radiations to kill the cancer cells left after surgery, shrink large tumors before the surgery or relieve symptoms of colon cancer. Usually combined with chemotherapy, radiation therapy aids in reducing the risk of recurrence.
According to the Colon Cancer Alliance, colon cancer is the third most commonly diagnosed and second leading cause of cancer in the U.S. Rising incidences of colon cancer and high pricing of products have attracted pharmaceutical companies to develop and market new products.
Access Full Report@ https://www.persistencemarketresearch.com/checkout/5423
Healthcare practitioners are now cautioned with the cost-benefit ratio of colon cancer drugs owing to large presence and high pricing of products in this market. Extensive research and development in this field is expected to provide better and more effective medications in the future.
Key Questions Answered in the Colon Cancer Market Report
How is the Colon Cancer Market expected to grow over the projected period?
What direction is the Colon Cancer Market expected to take in terms of volume and value during the forecast period?
What is the impact of macroeconomic factors on the Colon Cancer Market in future?
What are the key market drivers in the Colon Cancer Market?
What are significant opportunities and improvement areas for Colon Cancer Market manufacturers?
What are the key developments and trends taking over the Colon Cancer Market?
Which are the emerging countries that are expected to create significant growth opportunities in the Colon Cancer Market?
About us: Persistence Market Research
Contact us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com